Home Newsfeeds Watching Uxin Limited; Zacks Small Cap Research Sets 11.25 Price Valuation

Watching Uxin Limited; Zacks Small Cap Research Sets 11.25 Price Valuation

https://s27.q4cdn.com/906368049/files/News/2023/Zacks_SCR_Research_01052023_UXIN_Kerr.pdf

byBenzinga Newsdesk

January 5, 2023

1 minute read

https://s27.q4cdn.com/906368049/files/News/2023/Zacks_SCR_Research_01052023_UXIN_Kerr.pdf

Blackstone CEO Says Worried Investors Behind REIT Redemptions

By Vandana Singh

December 8, 11:35 AM

Blackstone Inc's (NYSE: BX) CEO Stephen Schwarzman said that worried investors drove redemptions from its $69 billion unlisted real estate income trust (REIT) due to market volatility rather than dissatisfaction with the fund.

News

‘Pentagon Weighs Microsoft Licensing Upgrades’ – Axios

By Benzinga Newsdesk

May 17, 12:30 PM

https://www.axios.com/2024/05/17/pentagon-weighs-microsoft-licensing-upgrades

MSFT

Charles River And PathoQuest Announce Publication Of A Head-To-Head Study Validating Proprietary Next Generation Sequencing Viral Safety Assay As A Reliable In Vitro Alternative To Animal Testing Methods

By Happy Mohamed

September 6, 8:20 AM

NGS assay demonstrated a broader detection range than standard in vivo tests with comparable or higher analytical sensitivity Charles River Laboratories International, Inc. (NYSE:CRL) and PathoQuest SAS, a leader in the

CRL